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ABSTRACT
In this commentary we consider the validity of tobacco
industry-funded research on the effects of standardised
packaging in Australia. As the ﬁrst country to introduce
standardised packs, Australia is closely watched, and
Philip Morris International has recently funded two
studies into the impact of the measure on smoking
prevalence. Both of these papers are ﬂawed in
conception as well as design but have nonetheless been
widely publicised as cautionary tales against
standardised pack legislation. Speciﬁcally, we focus on
the low statistical signiﬁcance of the analytical methods
used and the assumption that standardised packaging
should have an immediate large impact on smoking
prevalence.
An increasing number of countries are considering
legislation to enforce standardised tobacco pack-
aging (also known as ‘plain packaging’) consistent
with the Framework Convention on Tobacco
Control provision to prevent false, misleading or
deceptive labelling.1 Tobacco industry resistance to
such legislation is increasing, as demonstrated by
their funding of two working papers which claim
that standardised packaging has had no impact on
smoking prevalence in Australia, the ﬁrst country
to have successfully introduced this measure.2 3
The ﬁrst working paper focused on children aged
14–17 years and the second on adults. The former
has been criticised thoroughly elsewhere,4–6 but
although the authors reject these criticisms,7 the
second shares many of the same ﬂaws and biases.
There are two core issues to consider. The ﬁrst is
that the introduction of standardised packaging is
not expected to have a sudden impact on smoking
prevalence, but rather to impact on the rate of
smoking uptake. The second is that both papers are
not in fact powered to detect any plausible impact.
We examine the arguments in detail and focus on
the second paper, on adults, though our observa-
tions apply to both.
Both working papers use the Roy Morgan Single
Source (Australia) data set, from January 2001 to
December 2013, and calculate monthly smoking
prevalence over the period. The authors assert that
the data for the working paper on children are pub-
licly available, although they have to be purchased.
They note that data for the adult working paper were
“provided to us by Philip Morris International.”
In both papers, the authors ﬁrst construct a
linear time trend of the decline in smoking preva-
lence over an extended period before the introduc-
tion of standardised packaging, which has been
driven by a range of tobacco control measures.
The papers then assess whether the observed
decline after the standardised packaging measure
was introduced signiﬁcantly exceeds the level pre-
dicted by the linear trend. To do so they assess
whether the deviations from this trend are different
in the year after the legislation compared to the
year before, and ﬁnally they compute 90% CIs
around the monthly prevalence ﬁgures to see if
these span the extended trend line. These working
papers show that the declining trend in smoking
prevalence averaged 0.48 percentage points per
year at all ages in Australia over the period (and
0.44% for children) and continues to fall at a
similar rate after the introduction of standardised
packaging. This is interpreted as a lack of evidence
for effectiveness of the measure.
Such a continued decline is likely a positive sign
given that, as prevalence reaches very low levels, the
proportion of more addicted smokers who ﬁnd it
more difﬁcult to quit increases.8 This therefore means
that a continuation of the same rate of decline in this
context, rather than a levelling off, in fact likely repre-
sents an increase in effectiveness of tobacco control
measures. Any determination of statistical power in
the analysis presented needs to rest on the assumption
that the new legislation would increase the rate of
decline, rather than simply retaining it.
A sudden decline in smoking prevalence was not
envisaged in this legislation,9 with any effect
expected to be predominantly around initiation of
smoking rather than rates of quitting. Experts who
had commented on the legislation prior to imple-
mentation (in a research paper cited by the authors
in their working paper on adults) estimated that
even 2 years would be too short a timespan in
which to witness the full impact of standardised
packaging measures.10 Hence, the immediate effect
being sought is implausible, partly due to these
time lags and partly due to the inadequacy of
prevalence as a measure in this context. The nature
of addiction is such that any impact on quitting is
likely to take place over several years and a small
increase in the rate of decline may be more realistic
than an immediate dramatic fall in prevalence.
Even if the assumption of an immediate decline
is accepted, the analysis of statistical power in both
papers is opaque. The authors claim that ‘the
power of our inference models is remarkably high’,
supporting their argument with results of Monte
Carlo simulations, and calculating a power of 0.85
to detect a 0.5% reduction in prevalence. These
calculations are based on achieving statistical signiﬁ-
cance in any 1 of 12 tests, and the authors fail to
emphasise that these high-power calculations result
from considering all tests simultaneously
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(information that is hidden in technical details of their report).
They fail to quote the corresponding signiﬁcance level, which
needs to be on the same basis (combined across all 12 tests), and
erroneously claim their power applies at the 5% signiﬁcance
level. While the signiﬁcance level associated with one CI being
entirely below that expected based on extending the time trend
is 5% (based on one side of 90% CIs), the signiﬁcance level
associated with any 1 of the 12 CIs (across the 12-month time
period) being entirely below that expected is 46% (since the
probability of no signiﬁcant result out of 12 tests=0.9512
=0.54, giving a signiﬁcance level of 46%). The convoluted
nature of the analytical description also obscures whether there
were in fact 13 tests rather than 12—nevertheless, the signiﬁ-
cance level would still be approximately 50% for 13 tests.
For the second paper on adults, the authors also amended the
overall deﬁnition of signiﬁcance used to calculate power (ie, they
remove December 2012 from their analysis), which avoids overall
signiﬁcance favouring standardised packaging (by the deﬁnition
that they use to calculate power, based on signiﬁcance on any one
of several tests). Such amendments raise additional concerns about
the ad hoc nature of the approach used in these working papers.
A more suitable model would therefore be one in which the
potential impact of standardised packaging effect is gradual,
increasing linearly to reach the predicted decrease at the end of
a given period (ﬁgure 1). We have performed a Monte Carlo
simulation using the gradual effect model just described and a
t test, which is everywhere more powerful than the CI method.
The power ﬁgures we have obtained are shown in table 1, side
by side with the power ﬁgures published in the second working
paper. One can see that they are quite different. This table
emphasises the issues with their claim that “From January 2013
on, even very powerful statistical techniques no longer can pick
up any change from the pre-existing trend.” Simply put, the
data—although suggestive of a standardised packaging effect—
and the method used to analyse it, do not permit any inference
one way or the other. The same can be said of their ﬁrst
working paper on children. Although data on uptake of
smoking speciﬁcally rather than prevalence would allow a stron-
ger research design, a statistical analysis of this gradual effect
would be a more appropriate use of the available data.
Both of these working papers have been heavily publicised by
the tobacco industry, continuing a tradition of misrepresenting
evidence.11 The publication of the adult paper on the website of
the University of Zürich was accompanied by a media release
issued by the Institute for Policy Evaluation, which had been
commissioned by Philip Morris International to carry out the
study. This claimed that “The experts found no evidence for a
standardized packaging effect on smoking prevalence using
standard techniques for statistical analysis, in particular requir-
ing a statistical signiﬁcance level of 5%, which is the standard in
applied research.” Several major tobacco companies have addi-
tionally referred to these papers in their response to the UK
consultation on standardised packaging, for example, Philip
Morris Limited submitted that:
In both studies, using standard techniques for statistical analysis
and applying the standard statistical signiﬁcance level of 5%, the
experts found no evidence that “standardised packaging” had had
an effect on smoking prevalence among Australians aged 14 to 17
years old (in the case of the March study) or Australians aged 14
and above (in the case of the June study). Kaul and Wolf con-
ﬁrmed that if there had been an effect in reality […] it would have
been reﬂected in the data. According to the study, however, no
effect was found.12
The publication of the initial paper on children was in the
lead up to the publication of the Chantler review on standar-
dised packaging in England, which, despite this, supported it as
a means to reduce smoking. There is a continuing need to guard
against such misrepresentations of the evidence as other coun-
tries look to Australia to inform their own policies of standar-
dised packaging. Nevertheless, despite such opposition from the
tobacco industry the most recent Australian government data
show that smoking rates have in fact fallen to a historic low of
12.8%.13 There is also additional positive news in that other
countries, including the UK, New Zealand and Ireland, are also
now moving towards the introduction of standardised packaging
to protect the health of their populations.
Figure 1 Illustration of sudden and
gradual decline models used in power
calculation (Δ=prevalence reduction
being tested; K&W, Kaul and Wolf ).
Table 1 Comparison of the power claimed by Kaul and Wolf in
their second paper on adults with the actual power (t test with
p=0.05, as this is the best they can achieve, invoking a gradual
effect of standardised packaging, and obtained using Monte Carlo
simulation with 50 000 iterations)
Effect size (percentage
point reduction)
Power
Claimed Actual
0.25 0.67 0.11
0.50 0.85 0.22
0.75 0.96 0.37
1.00 0.99 0.55
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